Evidence map›Paper›PMID 40124847›Full record

ArticleGout, urate, and crystal deposition disease2024

Obesity-Associated Hyperuricemia in Female Mice: A Reevaluation.

Andrew P Giromini, Sonia R Salvatore, Brooke A Maxwell, Sara E Lewis, Michael R Gunther, Marco Fazzari, Francisco J Schopfer, Roberta Leonardi, Eric E Kelley

Abstract read
In one paragraph

Article in Gout, urate, and crystal deposition disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrew P GirominiWest Virginia University Departments of Biochemistry and Molecular Medicine, Morgantown, WV, USA.
Sonia R SalvatoreUniversity of Pittsburgh, Department of Pharmacology and Chemical Biology, Pittsburgh, PA, USA.
Brooke A MaxwellWest Virginia University Departments of Physiology, Pharmacology and Toxicology, Morgantown, WV, USA.
Sara E LewisWest Virginia University Departments of Physiology, Pharmacology and Toxicology, Morgantown, WV, USA.
Michael R GuntherWest Virginia University Departments of Biochemistry and Molecular Medicine, Morgantown, WV, USA.
Marco FazzariUniversity of Pittsburgh, Department of Pharmacology and Chemical Biology, Pittsburgh, PA, USA.
Francisco J SchopferUniversity of Pittsburgh, Department of Pharmacology and Chemical Biology, Pittsburgh, PA, USA.
Roberta LeonardiWest Virginia University Departments of Biochemistry and Molecular Medicine, Morgantown, WV, USA.
Eric E KelleyWest Virginia University Departments of Physiology, Pharmacology and Toxicology, Morgantown, WV, USA.

Funding

Changes in Coenzyme A Levels are a Key Mechanism Regulating Metabolic PathwaysR35GM119528 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Roberta Leonardi · 2016 to 2026
$4.4M
Formation and metabolism of nitrated fatty acidsR01GM125944 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCHOPFER, FRANCISCO JOSE · 2018 to 2025
$3.4M
Nitro-nitrate fatty acid derivatives as novel cGMP-dependent and cGMP-independent signaling mediatorsR01HL162787 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Marco Fazzari · 2023 to 2026
$2.4M
Role of Xanthine Oxidase in Heme-induced Vascular DysfunctionR01HL153532 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELLEY, ERIC EUGENE, STRAUB, ADAM CARL · 2021 to 2024
$2.1M
Targeting Uric Acid as a Therapeutic for NASHR01DK124510 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KELLEY, ERIC EUGENE, KHOO, NICHOLAS · 2020 to 2023
$1.4M
NHLBI NIH HHS R01 HL153532NHLBI NIH HHS R01 HL162787NIDDK NIH HHS R01 DK124510NIGMS NIH HHS R01 GM125944NIGMS NIH HHS R35 GM119528
6 · The paper itself

Abstract

Many preclinical reports have coalesced to identify a strong association between obesity and increased levels of uric acid (UA) in tissues and, importantly in the circulation (hyperuricemia). Unfortunately, nearly all these studies were conducted with male mice or, in one case, female mice without a side-by-side male cohort. Therefore, the relationship between obesity and hyperuricemia in female mice remains undefined. This lack of clarity in the field has considerable impact as the downstream effects of obesity and allied hyperuricemia are extensive, resulting in many comorbidities including cardiovascular dysfunction, chronic kidney disease and nonalcoholic fatty liver disease (NAFLD). Herein we begin to address this issue by revealing phenotypic and metabolic responses to diet-induced obesity (DIO) in a side-by-side male vs. female C57BL/6J study. Beginning at 6 weeks of age, mice were exposed to either an obesogenic diet (60% calories from fat) or control diet (10% calories from fat) for 19 weeks. Similar to numerous reported observations with the 60% diet, male mice experienced significant weight gain over time, elevated fasting blood glucose, impaired glucose tolerance and significantly elevated circulating uric acid levels (2.54 ± 0.33 mg/dL) compared to age-matched lean male controls (1.53 ± 0.19 mg/dL). As expected, the female mice experienced a slower rate of weight gain compared to the males; however, they also developed elevated fasting blood glucose and impaired glucose tolerance compared to age-matched lean controls. Countervailing our previous report whereby the control diet for the female-only study was vivarium standard chow (18% calories from fat), the obese female mice did demonstrate significantly elevated circulating UA levels (2.55 ± 0.15 mg/dL) compared to the proper control (1.68 ± 0.12 mg/dL). This affirms that the choice of control diet is crucial for reaching durable conclusions.

Indexed as

diet-induced obesityfemale micehyperuricemiaimpaired glucose toleranceuric acidxanthine oxidoreductase

Identifiers

PMID40124847
PMCPMC11928164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.